¶ KCNK1 Gene - Two-Pore Domain Potassium Channel
KCNK1 (Potassium Two Pore Domain Channel Subfamily K Member 1) encodes the TWIK-1 potassium channel, a member of the two-pore domain (K2P) potassium channel family. These channels contribute to the background "leak" conductance that maintains the resting membrane potential and regulate neuronal excitability [1]. This page covers the gene structure, protein function, and its implications in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS).
| Property |
Value |
| Gene Symbol |
KCNK1 |
| Full Name |
Potassium Two Pore Domain Channel Subfamily K Member 1 |
| Aliases |
TWIK-1, K2P1.1, TASK-1 (related family) |
| Chromosomal Location |
1q42.12 |
| NCBI Gene ID |
3775 |
| OMIM |
603457 |
| Ensembl ID |
ENSG00000135750 |
| UniProt ID |
O00180 |
| Gene Length |
7.8 kb |
| Exons |
4 |
¶ Protein Structure and Function
K2P channels contain:
- Four transmembrane domains
- Two pore regions (P1 and P2) in tandem
- Extracellular loop between transmembrane helices
- Form functional dimers (homodimers or heterodimers)
The TWIK-1 channel has a characteristic selectivity filter with the sequence GFG [2].
KCNK1/TWIK-1 contributes to background potassium conductance ("leak" currents") with several key functions:
| Function |
Mechanism |
Significance |
| Resting membrane potential |
Background K+ leak conductance |
Sets resting potential around -70 mV |
| Neuronal excitability |
Determines input resistance |
Modulates firing threshold |
| Cell volume regulation |
Responds to osmotic stress |
Volume-sensitive K+ efflux |
| Metabolic coupling |
ATP-sensitive mechanisms |
Links metabolism to excitability |
| Neuroprotection |
Limits Na+ influx during stress |
Prevents excitotoxicity |
KCNK1 is widely expressed:
- Brain: High expression in cortex, hippocampus, cerebellum
- Heart: Cardiac myocytes
- Kidney: Tubular epithelial cells
- Lung: Alveolar cells
- Pancreas: Islet cells
In the brain, TWIK-1 is present in neurons and astrocytes, contributing to astrocytic K+ buffering [3].
K2P channels, including TWIK-1, are affected in AD through multiple mechanisms:
- Amyloid-beta effects: Aβ oligomers alter K2P channel expression and function [4].
- Calcium dysregulation: K2P channels are calcium-sensitive and affected by AD-related calcium dysregulation.
- Neuronal hyperexcitability: Reduced K2P function contributes to network hyperactivity in early AD [5].
- Mitochondrial dysfunction: K2P channels affect mitochondrial K+ fluxes.
Studies show altered K2P expression in AD hippocampus, contributing to seizure-like activity [6].
TWIK-1 alterations in PD include:
- Dopaminergic neuron vulnerability: K2P dysfunction may increase excitotoxicity [7].
- alpha-synuclein interaction: αSyn may affect K2P channel trafficking.
- Mitochondrial stress: Altered K+ handling in PD models [8].
- Glial contributions: Astrocytic K2P dysfunction affects extracellular K+ clearance.
In ALS:
- Motor neuron hyperexcitability: K2P dysfunction contributes to excessive firing [9].
- Excitotoxicity: Altered K+ gradients affect glutamate transporter function.
- Energy metabolism: K2P channels influence neuronal energy demands.
K2P channels are well-established in epilepsy:
- Hyperexcitability: Loss of leak conductance leads to depolarized rest [10].
- Mutation links: KCNK1 mutations associated with epilepsy phenotypes [11].
- Therapeutic potential: K2P modulators under investigation for seizure control.
TWIK-1 interacts with several signaling pathways:
| Pathway |
Interaction |
Effect |
| p38 MAPK |
Phosphorylation |
Reduces channel activity |
| PKC |
Activation |
Modulates trafficking |
| Calmodulin |
Ca2+ binding |
Calcium sensitivity |
| ATP |
Direct binding |
Metabolic regulation |
- Phosphorylation: p38 MAPK and PKC modulate TWIK-1 activity [12].
- Trafficking: Channel insertion/removal from plasma membrane.
- Alternative splicing: Generates variants with different properties.
- Heterodimerization: Forms channels with other K2P subunits (TASK, TREK).
K2P channels are emerging therapeutic targets:
| Approach |
Status |
Indication |
| K2P activators |
Preclinical |
Neuroprotection |
| K2P blockers |
Clinical trials |
Analgesia |
| TASK-1 selective |
Preclinical |
Epilepsy |
| TWIK-1 modulators |
Discovery |
AD/PD |
Key areas for development:
- Neuroprotective strategies: K2P activators for AD/PD.
- Anti-epileptic drugs: Novel K2P-targeting compounds.
- Analgesics: K2P3/TWIK-1 in pain pathways [13].
- Antiarrhythmics: Cardiac K2P modulators.
- Lesage F, et al. (1996). TWIK-1: a ubiquitous background potassium channel. J Biol Chem
- Goldstein SA, et al. (2001). K2P potassium channels: new functions. Trends Neurosci
- Reyes R, et al. (1998). TWIK-1, a ubiquitous background K+ channel. Pflugers Arch
- Talley EM, et al. (2001). Distribution of neuronal two-pore domain K+ channels. J Neurosci
- Shieh CC, Coghlan M, Sullivan JP, Gopalakrishnan M, Potassium channels: molecular defects, diseases, and therapeutic opportunities (2000)
- Wei AD, Gutman GA, Aldrich R, et al, International Union of Pharmacology (2005)
- Coetzee WA, Amarillo Y, Chiu J, et al, Molecular diversity of K+ channel function and structure (1999)
- Rudy B, Sen K, Vega-Beltrán J, et al, The Kv3 channels: voltage-gated K+ channels highly expressed in brain (1999)
- Hille B, Ion channels of excitable membranes (2001)
- Nerbonne JM, Kass RS, Molecular physiology of cardiac repolarization (2005)
- Stocker M, Ca2+-activated K+ channels: molecular determinants and function (2004)
- Lesage F, et al. TWIK-1: a ubiquitous background potassium channel (1996)
- Goldstein SA, et al. K2P potassium channels: new functions (2001)
- Reyes R, et al. TWIK-1, a ubiquitous background K+ channel (1998)
- Talley EM, et al. Distribution of neuronal two-pore domain K+ channels (2001)
- Patel AJ, et al. TWIK-1 and TREK-1 are background K+ channels (2000)
- Aller MI, et al. Modulation of K2P channels by general anesthetics (2005)